Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in CancerCitation formats

  • Authors:
  • Surinder M. Soond
  • Maria V Kozhevnikova
  • Paul Townsend
  • Andrey A Zamyatnin

Standard

Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer. / Soond, Surinder M.; Kozhevnikova, Maria V; Townsend, Paul; Zamyatnin, Andrey A.

In: Pharmaceuticals (Basel, Switzerland), Vol. 12, No. 2, 11.06.2019.

Research output: Contribution to journalReview article

Harvard

Soond, SM, Kozhevnikova, MV, Townsend, P & Zamyatnin, AA 2019, 'Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer', Pharmaceuticals (Basel, Switzerland), vol. 12, no. 2. https://doi.org/10.3390/ph12020087

APA

Soond, S. M., Kozhevnikova, M. V., Townsend, P., & Zamyatnin, A. A. (2019). Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer. Pharmaceuticals (Basel, Switzerland), 12(2). https://doi.org/10.3390/ph12020087

Vancouver

Author

Soond, Surinder M. ; Kozhevnikova, Maria V ; Townsend, Paul ; Zamyatnin, Andrey A. / Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer. In: Pharmaceuticals (Basel, Switzerland). 2019 ; Vol. 12, No. 2.

Bibtex

@article{9786e08fe85e4a47b2b25cbffb5ae4ed,
title = "Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer",
abstract = "In keeping with recent developments in basic research; the importance of the Cathepsins as targets in cancer therapy have taken on increasing importance and given rise to a number of key areas of interest in the clinical setting. In keeping with driving basic research in this area in a translational direction; recent findings have given rise to a number of exciting developments in the areas of cancer diagnosis; prognosis and therapeutic development. As a fast-moving area of research; the focus of this review brings together the latest findings and highlights the translational significance of these developments.",
author = "Soond, {Surinder M.} and Kozhevnikova, {Maria V} and Paul Townsend and Zamyatnin, {Andrey A}",
year = "2019",
month = "6",
day = "11",
doi = "10.3390/ph12020087",
language = "English",
volume = "12",
journal = "Pharmaceuticals",
issn = "1424-8247",
publisher = "M D P I AG",
number = "2",

}

RIS

TY - JOUR

T1 - Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer

AU - Soond, Surinder M.

AU - Kozhevnikova, Maria V

AU - Townsend, Paul

AU - Zamyatnin, Andrey A

PY - 2019/6/11

Y1 - 2019/6/11

N2 - In keeping with recent developments in basic research; the importance of the Cathepsins as targets in cancer therapy have taken on increasing importance and given rise to a number of key areas of interest in the clinical setting. In keeping with driving basic research in this area in a translational direction; recent findings have given rise to a number of exciting developments in the areas of cancer diagnosis; prognosis and therapeutic development. As a fast-moving area of research; the focus of this review brings together the latest findings and highlights the translational significance of these developments.

AB - In keeping with recent developments in basic research; the importance of the Cathepsins as targets in cancer therapy have taken on increasing importance and given rise to a number of key areas of interest in the clinical setting. In keeping with driving basic research in this area in a translational direction; recent findings have given rise to a number of exciting developments in the areas of cancer diagnosis; prognosis and therapeutic development. As a fast-moving area of research; the focus of this review brings together the latest findings and highlights the translational significance of these developments.

U2 - 10.3390/ph12020087

DO - 10.3390/ph12020087

M3 - Review article

VL - 12

JO - Pharmaceuticals

JF - Pharmaceuticals

SN - 1424-8247

IS - 2

ER -